150 related articles for article (PubMed ID: 35535222)
1. Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis.
Gobejishvili L; Rodriguez WE; Bauer P; Wang Y; Soni C; Lydic T; Barve S; McClain C; Maldonado C
Drug Des Devel Ther; 2022; 16():1301-1309. PubMed ID: 35535222
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents.
Gong MF; Wen RT; Xu Y; Pan JC; Fei N; Zhou YM; Xu JP; Liang JH; Zhang HT
Psychopharmacology (Berl); 2017 Oct; 234(20):3143-3151. PubMed ID: 28748375
[TBL] [Abstract][Full Text] [Related]
3. PAN-selective inhibition of cAMP-phosphodiesterase 4 (PDE4) induces gastroparesis in mice.
McDonough W; Aragon IV; Rich J; Murphy JM; Abou Saleh L; Boyd A; Koloteva A; Richter W
FASEB J; 2020 Sep; 34(9):12533-12548. PubMed ID: 32738081
[TBL] [Abstract][Full Text] [Related]
4. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
[TBL] [Abstract][Full Text] [Related]
5. Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
Tang HF; Lu JJ; Tang JF; Zheng X; Liang YQ; Wang XF; Wang YJ; Mao LG; Chen JQ
Int Immunopharmacol; 2010 Apr; 10(4):406-11. PubMed ID: 20074667
[TBL] [Abstract][Full Text] [Related]
6. The identification of a novel phosphodiesterase 4 inhibitor, 1-ethyl-5-{5-[(4-methyl-1-piperazinyl)methyl]-1,3,4-oxadiazol-2-yl}-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (EPPA-1), with improved therapeutic index using pica feeding in rats as a measure of emetogenicity.
Davis TG; Peterson JJ; Kou JP; Capper-Spudich EA; Ball D; Nials AT; Wiseman J; Solanke YE; Lucas FS; Williamson RA; Ferrari L; Wren P; Knowles RG; Barnette MS; Podolin PL
J Pharmacol Exp Ther; 2009 Sep; 330(3):922-31. PubMed ID: 19498103
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
Hu W; Lu T; Chen A; Huang Y; Hansen R; Chandler LJ; Zhang HT
Psychopharmacology (Berl); 2011 Nov; 218(2):331-9. PubMed ID: 21509503
[TBL] [Abstract][Full Text] [Related]
8. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
Guo CH; Bai L; Wu HH; Yang J; Cai GH; Wang X; Wu SX; Ma W
Int J Mol Med; 2016 Nov; 38(5):1433-1442. PubMed ID: 28025994
[TBL] [Abstract][Full Text] [Related]
9. Chlorbipram: a novel PDE4 inhibitor with improved safety as a potential antidepressant and cognitive enhancer.
Zhang MZ; Zhou ZZ; Yuan X; Cheng YF; Bi BT; Gong MF; Chen YP; Xu JP
Eur J Pharmacol; 2013 Dec; 721(1-3):56-63. PubMed ID: 24113523
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1.
Korhonen R; Hömmö T; Keränen T; Laavola M; Hämäläinen M; Vuolteenaho K; Lehtimäki L; Kankaanranta H; Moilanen E
Br J Pharmacol; 2013 Aug; 169(7):1525-36. PubMed ID: 23849041
[TBL] [Abstract][Full Text] [Related]
11. The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1.
Lima KM; Vago JP; Caux TR; Negreiros-Lima GL; Sugimoto MA; Tavares LP; Arribada RG; Carmo AAF; Galvão I; Costa BRC; Soriani FM; Pinho V; Solito E; Perretti M; Teixeira MM; Sousa LP
J Biol Chem; 2017 Aug; 292(33):13758-13773. PubMed ID: 28655761
[TBL] [Abstract][Full Text] [Related]
12. Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1-5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia.
Yu MC; Chen JH; Lai CY; Han CY; Ko WC
Eur J Pharmacol; 2010 Feb; 627(1-3):269-75. PubMed ID: 19853596
[TBL] [Abstract][Full Text] [Related]
13. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S
Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659
[TBL] [Abstract][Full Text] [Related]
14. Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.
Gobejishvili L; Barve S; Breitkopf-Heinlein K; Li Y; Zhang J; Avila DV; Dooley S; McClain CJ
J Pharmacol Exp Ther; 2013 Oct; 347(1):80-90. PubMed ID: 23887098
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
Dlaboga D; Hajjhussein H; O'Donnell JM
Brain Res; 2006 Jun; 1096(1):104-12. PubMed ID: 16730340
[TBL] [Abstract][Full Text] [Related]
16. Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model.
Boomkamp SD; McGrath MA; Houslay MD; Barnett SC
Br J Pharmacol; 2014 May; 171(9):2385-98. PubMed ID: 24467222
[TBL] [Abstract][Full Text] [Related]
17. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway.
Li Q; Peng Y; Fan L; Xu H; He P; Cao S; Li J; Chen T; Ruan W; Chen G
Biomed Pharmacother; 2018 Mar; 99():947-955. PubMed ID: 29710495
[TBL] [Abstract][Full Text] [Related]
19. PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway.
Robichaud A; Savoie C; Stamatiou PB; Tattersall FD; Chan CC
Neuropharmacology; 2001; 40(2):262-9. PubMed ID: 11114405
[TBL] [Abstract][Full Text] [Related]
20. Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.
Robichaud A; Stamatiou PB; Jin SL; Lachance N; MacDonald D; Laliberté F; Liu S; Huang Z; Conti M; Chan CC
J Clin Invest; 2002 Oct; 110(7):1045-52. PubMed ID: 12370283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
